nach oben

AIDS and Behavior

Erschienen in:

11.05.2021 | Original Paper

Assessing Provider-, Clinic-, and Structural-Level Barriers and Recommendations to Pre-Exposure Prophylaxis (PrEP) Uptake: A Qualitative Investigation Among Women Experiencing Intimate Partner Violence, Intimate Partner Violence Service Providers, and Healthcare Providers

verfasst von: Amy Caplon, Kamila A. Alexander, Trace Kershaw, Tiara C. Willie

Erschienen in: AIDS and Behavior | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Intimate partner violence (IPV) relates to HIV susceptibility and acquisition. Existing research examined barriers to pre-exposure prophylaxis (PrEP) uptake among women but few studies assess uptake and delivery among IPV service providers, along with provider-, clinic-, and structural-level barriers. We conducted 34 semi-structured interviews with PrEP-eligible cisgender heterosexual women experiencing IPV, Reproductive Health providers, PrEP providers, and IPV service providers in Northeast US. Systems theory was used to examine barriers from individuals who either work closely with or are part of the population. The framework method was used to draw descriptive and explanatory conclusions. Findings suggest limited knowledge for Reproductive Health and IPV Service Providers. Providers often did not feel equipped to discussed PrEP in visits or focused efforts solely on safety. Expanding PrEP awareness is necessary and marketing should include women. Future research should investigate how providers can work collaboratively across sectors to ensure women receive comprehensive trauma-informed care.

Centers for Disease Control and Prevention. Intersection of Intimate Partner Violence and HIV in Women. 2014. https://www.cdc.gov/violenceprevention/pdf/ipv/13_243567_Green_AAG-a.pdf. Accessed 20 Mar 2019.

Smith SG, Zhang X, Basile KC, et al. National intimate partner and sexual violence survey: 2015 data brief. Atlanta: National Center for Injury Prevention and Control Centers for Disease Control and Prevention; 2018.

Smith, SG, Chen, J, Basile, KC, et al. (2017). The National Intimate Partner and Sexual Violence Survey (NISVS): 2010-2012 State Report. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.

Sareen J, Pagura J, Grant B. Is intimate partner violence associated with HIV infection among women in the United States? Gen Hosp Psychiatry. 2009;31(3):274–8.CrossRefPubMed

Dunkle KL, Decker MR. Gender-based violence and HIV: reviewing the evidence for links and causal pathways in the general population and high risk groups. Am J Reprod Immunol. 2013;69:20–6.CrossRefPubMed

Gielen AC, Ghandour RM, Burke JG, Mahoney P, McDonnell KA, O’Campo P. HIV/AIDS and intimate partner violence: intersecting women’s health issues in the United States. Trauma Violence Abuse. 2007;8(2):178–98.CrossRefPubMed

Bradley EL, Hoover KW. Improving HIV preexposure prophylaxis implementation for women: summary of key findings from a discussion series with women’s HIV prevention experts. Women’s Health Issues. 2019;29(1):3–7.CrossRefPubMed

Wingood GM, DiClemente RJ. The effects of an abusive primary partner on the condom use and sexual negotiation practices of African-American women. Am J Public Health. 1997;87(6):1016–8. https://doi.org/10.2105/ajph.87.6.1016.CrossRefPubMedPubMedCentral

Mittal M, Senn TE, Carey MP. Intimate partner violence and condom use among women: does the information-motivation-behavioral skills (IMB) model explain sexual risk behavior? AIDS Behav. 2012;16(4):1011–9. https://doi.org/10.1007/s10461-011-9949-3.CrossRefPubMedPubMedCentral

10.

Minton HAM, Mittal M, Elder H, Carey MP. Relationship factors and condom use among women with a history of intimate partner violence. AIDS Behav. 2016;20(1):225–34. https://doi.org/10.1007/s10461-015-1189-5.CrossRef

11.

Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102–10. https://doi.org/10.1089/apc.2014.0142.CrossRefPubMedPubMedCentral

12.

Calabrese SK, Krakower DS, Willie TC, Kershaw TS, Mayer KH. US guideline criteria for HIV pre-exposure prophylaxis: clinical considerations and caveats. Clin Infect Dis. 2019;69(5):884–9.CrossRefPubMedPubMedCentral

13.

Flash CA, Stone VE, Mitty JA, et al. Perspectives on HIV prevention among urban Black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2014;28(12):635–42.CrossRefPubMedPubMedCentral

14.

Garfinkel DB, Alexander KA, McDonald-Mosley R, Willie TC, Decker MR. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care. 2017;29(6):751–8.CrossRefPubMed

15.

Guest G, Shattuck D, Johnson L, et al. Acceptability of PrEP for HIV prevention among women at high risk for HIV. J Women’s Health. 2010;19(4):791–8.CrossRef

16.

Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R. Tenofovir-based oral PrEP prevents HIV infection among women. Curr Opin HIV AIDS. 2016;11(1):18.CrossRefPubMedPubMedCentral

17.

Willie T, Kershaw T, Campbell JC, Alexander KA. Intimate partner violence and PrEP acceptability among low-income, young black women: exploring the mediating role of reproductive coercion. AIDS Behav. 2017;21(8):2261–9.CrossRefPubMedPubMedCentral

18.

Willie TC, Stockman JK, Overstreet NM, Kershaw TS. Examining the impact of intimate partner violence type and timing on pre-exposure prophylaxis awareness, interest, and coercion. AIDS Behav. 2018;22(4):1190–200.CrossRefPubMedPubMedCentral

19.

Willie TC, Stockman JK, Keene DE, Calabrese SK, Alexander KA, Kershaw TS. Social networks and its impact on women’s awareness, interest, and uptake of HIV pre-exposure prophylaxis (PrEP): implications for women experiencing intimate partner violence. J Acquir Immune Defic Syndr. 2019;80(4):386–93.CrossRefPubMedPubMedCentral

20.

U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States- 2017 update. Atlanta: Centers for Disease Control and Prevention; 2017. p. 1–77.

21.

Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017 United States. Ann Epidemiol. 2018;28(12):841–9. https://doi.org/10.1016/j.annepidem.2018.06.005.CrossRefPubMedPubMedCentral

22.

Connecticut Department of Public Health. DPH HIV prevention interventions. Hartford: Connecticut Department of Public Health; 2017.

23.

Amico KR, Ramirez C, Caplan MR, et al. Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions. J Int AIDS Soc. 2019;22(3):e25247.CrossRefPubMedPubMedCentral

24.

Braksmajer A, Leblanc NM, El-Bassel N, Urban MA, McMahon JM. Feasibility and acceptability of pre-exposure prophylaxis use among women in violent relationships. AIDS Care. 2018;31(4):475–80. https://doi.org/10.1080/09540121.2018.1503634.CrossRefPubMed

25.

Braksmajer A, Senn TE, McMahon J. The potential of pre-exposure prophylaxis for women in violent relationships. AIDS Patient Care STDS. 2016;30(6):274–81. https://doi.org/10.1089/apc.2016.0098.CrossRefPubMedPubMedCentral

26.

Cabral A, Baeten JM, Ngure K, et al. Intimate partner violence and self-reported pre-exposure prophylaxis interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda. J Acquir Immune Defic Syndr. 2018;77(2):154–9.CrossRefPubMedPubMedCentral

27.

Roberts ST, Haberer J, Celum C, et al. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study. J Acquir Immune Defic Syndr. 2016;73(3):313–22.CrossRefPubMedPubMedCentral

28.

Willie TC, Keene DE, Kershaw TS, Stockman JK. “You never know what could happen”: women’s perspectives of pre-exposure prophylaxis in the context of recent intimate partner violence. Womens Health Issues. 2020;30(1):41–8.CrossRefPubMed

29.

Lai CH, Lin S, et al. Systems theory. In: Scott CR, et al., editors. The International Encyclopedia of Organizational Communication. New York: Wiley; 2017.

30.

Willie TC, Keene DE, Stockman JK, Alexander KA, Calabrese SK, Kershaw TS. Intimate partner violence influences women’s engagement in the early stages of the hiv pre-exposure prophylaxis (PrEP) care continuum: using doubly robust estimation. AIDS Behav. 2019;24(2):560–7.CrossRef

31.

Kershaw T, Murphy A, Divney A, Magriples U, Niccolai L, Gordon D. What’s love got to do with it: relationship functioning and mental and physical quality of life among pregnant adolescent couples. Am J Community Psychol. 2013;52(3–4):288–301. https://doi.org/10.1007/s10464-013-9594-2.CrossRefPubMedPubMedCentral

32.

Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. https://doi.org/10.1186/1471-2288-13-117.CrossRefPubMedPubMedCentral

33.

Centers for Disease Control and Prevention. The Social-Ecological Model: A Framework for Prevention. 2020; https://www.cdc.gov/violenceprevention/publichealthissue/social-ecologicalmodel.html. Accessed 25 July 2020.

34.

Morse DS, Lafleur R, Fogarty CT, Mittal M, Cerulli C. “They told me to leave”: how health care providers address intimate partner violence. J Am Board Fam Med. 2012;25(3):333–42. https://doi.org/10.3122/jabfm.2012.03.110193.CrossRefPubMedPubMedCentral

35.

Hamberger LK, Rhodes K, Brown J. Screening and intervention for intimate partner violence in healthcare settings: creating sustainable system-level programs. J Womens Health. 2015;24(1):86–91. https://doi.org/10.1089/jwh.2014.4861.CrossRef

36.

Hegarty K, McKibbin G, Hameed M, et al. Health practitioners’ readiness to address domestic violence and abuse: a qualitative-synthesis. PLoS one. 2020;15(6):e0234067. https://doi.org/10.1371/journal.pone.0234067.CrossRefPubMedPubMedCentral

37.

Alvarez C, Debnam K, Clough A, Alexander KA, Glass N. Responding to intimate partner violence: healthcare providers’ current practices and views on integrating a safety decision aid into primary care settings. Res Nurs Health. 2018. https://doi.org/10.1002/nur.21853.CrossRefPubMed

38.

Koss CA, Charlesbois ED, Ayieko J, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet. 2020;7(4):249–61. https://doi.org/10.1016/S2352-3018(19)30433-3.CrossRef

Titel: Assessing Provider-, Clinic-, and Structural-Level Barriers and Recommendations to Pre-Exposure Prophylaxis (PrEP) Uptake: A Qualitative Investigation Among Women Experiencing Intimate Partner Violence, Intimate Partner Violence Service Providers, and Healthcare Providers
verfasst von: Amy Caplon
Kamila A. Alexander
Trace Kershaw
Tiara C. Willie
Publikationsdatum: 11.05.2021
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 10/2021
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-021-03297-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Efficacy of Psychological Interventions Towards the Reduction of High-Risk Sexual Behaviors Among People Living with HIV: A Systematic Review and Meta-analysis, 2010–2020

Substance Use Predicts Sustained Viral Suppression in a Community Cohort of Sexual and Gender Minority Youth Living with HIV

Syringe Coverage Among People Who Inject Drugs in West Virginia, USA

Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States

From Survival to Glamour: Motivations for Engaging in Transactional Sex and Relationships Among Adolescent Girls and Young Women in South Africa

Sexual Identity, Sexual Behavior and Pre-exposure Prophylaxis in Black Cisgender Sexual Minority Men: The N2 Cohort Study in Chicago